Form 4: Director Desai Acquires PROCEPT BioRobotics Stock

Director Antal Rohit Desai reported a transaction involving the acquisition of 3,315 shares of common stock and 5,853 stock options in PROCEPT BioRobotics Corp.

Summary

• Director Antal Rohit Desai acquired 3,315 shares of PROCEPT BioRobotics Corp. common stock on June 9, 2026.
• The acquisition was made at a price of $0 per share, indicating it was likely a grant or award.
• Following this transaction, Mr. Desai beneficially owns 38,467 shares of common stock.
• Additionally, Mr. Desai was granted 5,853 stock options with an exercise price of $28.78.
• These stock options are exercisable and expire on June 8, 2036.
• The stock options vest in full on the earlier of the one-year anniversary of the grant date or the next annual meeting, contingent on continued service.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents standard insider compensation and stock acquisition, indicating director commitment rather than significant new financial performance or strategic shifts.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• Grant of stock options suggests alignment of management incentives with shareholder value creation.
• The vesting schedule for RSUs and stock options encourages long-term commitment from the director.

Risks

• The filing does not contain information that would typically be considered a risk to the company or its operations.

Future Outlook

The future outlook is not directly addressed in this Form 4 filing, which primarily reports on insider transactions. However, the grant of stock options with a future vesting schedule implies management's expectation of continued company performance and value appreciation.

Industry Context

StockSavvy.ai notes that insider transactions, such as the acquisition of stock and options by directors, are common in the biotechnology and medical device sectors as a means to align executive interests with long-term shareholder value. PROCEPT BioRobotics operates in the robotic surgery space, a rapidly evolving field.

Stakeholder Impact

• Shareholders: The acquisition of stock and options by a director can be viewed positively as it aligns director interests with those of shareholders, potentially signaling confidence in the company's future performance.

Next Steps

• Vesting of restricted stock units and stock options according to the specified schedule.
• Continued service by Director Antal Rohit Desai.

Key Dates

Keywords

PROCEPT BioRobotics Corp, PRCT, Form 4, Insider Transaction, Stock Options, Restricted Stock Units, Director, Beneficial Ownership, SEC Filing